These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 36395551)

  • 1. Corrigendum to "Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharynx cancer: A multi-centre study" [Radiother. Oncol. 172 (2022) 111-117].
    Price JM; West CM; Dixon LM; Iyizoba-Ebozue Z; Garcez K; Lee LW; McPartlin A; Williams G; Slevin F; Sykes A; Prestwich RJD; Thomson DJ
    Radiother Oncol; 2022 Dec; 177():163. PubMed ID: 36395551
    [No Abstract]   [Full Text] [Related]  

  • 2. Similar long-term swallowing outcomes for accelerated, mildly-hypofractionated radiotherapy compared to conventional fractionation in oropharyngeal cancer: A multi-centre study.
    Price JM; West CM; Dixon LM; Iyizoba-Ebozue Z; Garcez K; Lee LW; McPartlin A; Slevin F; Sykes A; Prestwich RJD; Thomson DJ
    Radiother Oncol; 2022 Jul; 172():111-117. PubMed ID: 35595173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimising Radiation Therapy Dose to the Swallowing Organs at Risk: An In Silico Study of feasibility for Patients with Oropharyngeal Tumours.
    Barnhart MK; Cartmill B; Ward EC; Brown E; Sim J; Saade G; Rayner S; Robinson RA; Simms VA; Smee RI
    Dysphagia; 2019 Dec; 34(6):869-878. PubMed ID: 30741335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Corrigendum to "A feasibility study of high-dose hypofractionated carbon ion radiation therapy using four fractions for localized hepatocellular carcinoma measuring 3 cm or larger" [Radiother. Oncol. 132 (2019) 230-235].
    Shibuya K; Ohno T; Katoh H; Okamoto M; Shiba S; Koyama Y; Kakizaki S; Shirabe K; Nakano T
    Radiother Oncol; 2020 Feb; 143():126-127. PubMed ID: 32008869
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Interaction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy" [Radiother Oncol 150 (2020) 114-120].
    Chen D; Patel RR; Verma V; Ramapriyan R; Barsoumian HB; Angelica Cortez M; Welsh JW
    Radiother Oncol; 2021 May; 158():332-334. PubMed ID: 33714536
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Update of the systematic review of palliative radiation therapy fractionation for bone metastases" [Radiother. Oncol. 126 (2018) 547-557].
    Rich SE; Chow R; Raman S; Liang Zeng K; Lutz S; Lam H; Silva MF; Chow E
    Radiother Oncol; 2019 Jun; 135():201. PubMed ID: 30981439
    [No Abstract]   [Full Text] [Related]  

  • 7. Accelerated Hypofractionated Radiotherapy Versus Stereotactic Body Radiotherapy for the Treatment of Stage I Nonsmall Cell Lung Cancer-A Single Institution Experience With Long-Term Follow-Up.
    Karasawa K; Hayakawa S; Machitori Y; Shibata Y; Ogawa H; Ito K; Shimizuguchi T; Kawamoto T; Nihei K
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806318. PubMed ID: 30317929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial.
    Widmark A; Gunnlaugsson A; Beckman L; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Fransson P; Tavelin B; Norman D; Zackrisson B; Anderson H; Kjellén E; Franzén L; Nilsson P
    Lancet; 2019 Aug; 394(10196):385-395. PubMed ID: 31227373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corrigendum to "Geometric uncertainties in voluntary deep inspiration breath hold radiotherapy for locally advanced lung cancer" [Radiother. Oncol. 118 (2016) 510-514].
    Josipovic M; Persson GF; Dueck J; Peter Bangsgaard J; Westman G; Specht L; Aznar MC
    Radiother Oncol; 2019 Apr; 133():230. PubMed ID: 30773227
    [No Abstract]   [Full Text] [Related]  

  • 10. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial.
    Fransson P; Nilsson P; Gunnlaugsson A; Beckman L; Tavelin B; Norman D; Thellenberg-Karlsson C; Hoyer M; Lagerlund M; Kindblom J; Ginman C; Johansson B; Björnlinger K; Seke M; Agrup M; Zackrisson B; Kjellén E; Franzén L; Widmark A
    Lancet Oncol; 2021 Feb; 22(2):235-245. PubMed ID: 33444529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypofractionated Simultaneous Integrated Boost Radiotherapy Versus Conventional Fractionation Radiotherapy of Early Breast Cancer After Breast-Conserving Surgery: Clinical Observation and Analysis.
    Dong J; Yang Y; Han D; Zhao Q; Liu C; Sun H; Wang Z; Lin H; Huang W
    Technol Cancer Res Treat; 2021; 20():15330338211064719. PubMed ID: 34898315
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
    López Torrecilla J; Hervás A; Zapatero A; Gómez Caamaño A; Macías V; Herruzo I; Maldonado X; Gómez Iturriaga A; Casas F; González San Segundo C
    Rep Pract Oncol Radiother; 2016; 21(1):90-2. PubMed ID: 26900365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External beam radiation dose escalation for high grade glioma.
    Khan L; Soliman H; Sahgal A; Perry J; Xu W; Tsao MN
    Cochrane Database Syst Rev; 2020 May; 5(5):CD011475. PubMed ID: 32437039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comment on: "Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical Phase II trial" [Radiother Oncol 71(2):157-162, 2004 Dr Chen et al].
    Cengiz M; Selek U; Yildiz F; Sari S
    Radiother Oncol; 2005 Jan; 74(1):76-7; author reply 77-8. PubMed ID: 15683676
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Local control and postponement of systemic therapy after modest dose radiotherapy in oligometastatic myxoid liposarcomas" [Radiother. Oncol. 158 (2021) 33-39].
    Lansu J; van Houdt WJ; van Langevelde K; van den Ende PLA; van der Graaf WTA; Schrage Y; van Boven H; Scholten AN; Haas RL
    Radiother Oncol; 2021 Oct; 163():245. PubMed ID: 34243980
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Interaction between CIEDs and modern radiotherapy techniques: Flattening filter free-VMAT, dose-rate effects, scatter radiation, and neutron-generating energies" [Radiother Oncol 152 (2020) 196-202].
    Gauter-Fleckenstein B; Nguyen J; Jahnke L; Gaiser T; Rudic B; Büttner S; Wenz F; Borggrefe M; Tülümen E
    Radiother Oncol; 2021 Jan; 154():291. PubMed ID: 33460982
    [No Abstract]   [Full Text] [Related]  

  • 17. Rectal/urinary toxicity after hypofractionated vs conventional radiotherapy in low/intermediate risk localized prostate cancer: systematic review and meta analysis.
    Di Franco R; Borzillo V; Ravo V; Ametrano G; Falivene S; Cammarota F; Rossetti S; Romano FJ; D'Aniello C; Cavaliere C; Iovane G; Piscitelli R; Berretta M; Muto P; Facchini G
    Oncotarget; 2017 Mar; 8(10):17383-17395. PubMed ID: 28129649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postoperative hypofractionated-accelerated radiotherapy (HypoAR) for locally advanced rectal cancer.
    Koukourakis MI; Kavazis C; Giagtzidis A; Mamalis P; Tsaroucha A; Botaitis S; Giatromanolaki A; Pitiakoudis M
    Jpn J Clin Oncol; 2022 May; 52(5):493-498. PubMed ID: 35079795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "Commissioning and clinical implementation of an Autoencoder based Classification-Regression model for VMAT patient-specific QA in a multi-institution scenario" [Radiother. Oncol. 161 (2021) 230-240].
    Yang R; Yang X; Wang L; Li D; Guo Y; Li Y; Guan Y; Wu X; Xu S; Zhang S; Chan MF; Geng L; Sui J
    Radiother Oncol; 2021 Oct; 163():119-120. PubMed ID: 34488166
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis.
    Lacas B; Bourhis J; Overgaard J; Zhang Q; Grégoire V; Nankivell M; Zackrisson B; Szutkowski Z; Suwiński R; Poulsen M; O'Sullivan B; Corvò R; Laskar SG; Fallai C; Yamazaki H; Dobrowsky W; Cho KH; Beadle B; Langendijk JA; Viegas CMP; Hay J; Lotayef M; Parmar MKB; Aupérin A; van Herpen C; Maingon P; Trotti AM; Grau C; Pignon JP; Blanchard P;
    Lancet Oncol; 2017 Sep; 18(9):1221-1237. PubMed ID: 28757375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.